Phase Ⅲ Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations . J Clin Oncol,2013,1 . [ Epub ahead of print ].Jinji Yang,Ying Cheng,Mingfang Zhao . A phase Ⅱ trial comparing pemetrexed with gefi ......